These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25092460)

  • 41. Inhibition of HCV by the serpin antithrombin III.
    Asmal M; Seaman M; Lin W; Chung RT; Letvin NL; Geiben-Lynn R
    Virol J; 2012 Oct; 9():226. PubMed ID: 23031791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice.
    Ohno M; Shibata C; Kishikawa T; Yoshikawa T; Takata A; Kojima K; Akanuma M; Kang YJ; Yoshida H; Otsuka M; Koike K
    Sci Rep; 2013; 3():2553. PubMed ID: 23989853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-targeting therapeutics for hepatitis C.
    Baek J; Kang S; Min H
    Arch Pharm Res; 2014 Mar; 37(3):299-305. PubMed ID: 24385319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs: Role in Hepatitis C Virus pathogenesis.
    Shrivastava S; Steele R; Ray R; Ray RB
    Genes Dis; 2015 Mar; 2(1):35-45. PubMed ID: 25984557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus infection, microRNA and liver disease progression.
    Shrivastava S; Mukherjee A; Ray RB
    World J Hepatol; 2013 Sep; 5(9):479-86. PubMed ID: 24073299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?
    Sikorska K; Stalke P; Bielawski KP
    J Hepatol; 2011 Jul; 55(1):235-6: author reply 236-7. PubMed ID: 21236307
    [No Abstract]   [Full Text] [Related]  

  • 47. MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
    Cawood R; Wong SL; Di Y; Baban DF; Seymour LW
    PLoS One; 2011 Jan; 6(1):e16152. PubMed ID: 21264344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deal watch: GSK invests in targeting microRNA for the treatment of hepatitis C.
    Nat Rev Drug Discov; 2010 May; 9(5):350. PubMed ID: 20431557
    [No Abstract]   [Full Text] [Related]  

  • 49. Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity.
    Qian S; Fan W; Qian P; Zhang D; Wei Y; Chen H; Li X
    Viruses; 2015 Mar; 7(4):1613-26. PubMed ID: 25835532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral entry inhibition: too late for hepatitis C, but promising for other viral infections.
    Pawlotsky JM
    Gut; 2015 Mar; 64(3):362-4. PubMed ID: 25098973
    [No Abstract]   [Full Text] [Related]  

  • 51. Regulation of NS5B Polymerase Activity of Hepatitis C Virus by Target Specific Phytotherapeutics: An In-Silico Molecular Dynamics Approach.
    Dhanasekaran S; Selvadoss PP; Manoharan SS; Jeyabalan S; Yaraguppi DA; Choudhury AA; Rajeswari VD; Ramanathan G; Thamaraikani T; Sekar M; Subramaniyan V; Shing WL
    Cell Biochem Biophys; 2024 Sep; 82(3):2473-2492. PubMed ID: 39042185
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Mandalari G; Pennisi R; Gervasi T; Sciortino MT
    Front Microbiol; 2024; 15():1396514. PubMed ID: 39011148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic approaches for chronic hepatitis C: a concise review.
    Nawaz A; Manzoor A; Ahmed S; Ahmed N; Abbas W; Mir MA; Bilal M; Sheikh A; Ahmad S; Jeelani I; Nakagawa T
    Front Pharmacol; 2023; 14():1334160. PubMed ID: 38283838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of immune modulators and immunotherapy in infectious diseases.
    Sangeetha Vijayan P; Xavier J; Valappil MP
    Mol Cell Biochem; 2024 Aug; 479(8):1937-1955. PubMed ID: 37682390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into the pharmacological and therapeutic effects of apigenin in liver injuries and diseases.
    Bi C; Han W; Yu J; Zhang H; Xing G; Liu Z
    Heliyon; 2023 May; 9(5):e15609. PubMed ID: 37144193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review.
    Khan FB; Singh P; Jamous YF; Ali SA; Abdullah ; Uddin S; Zia Q; Jena MK; Khan M; Owais M; Huang CY; Chanukuppa V; Ardianto C; Ming LC; Alam W; Khan H; Ayoub MA
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved Activity of Herbal Medicines through Nanotechnology.
    Dewi MK; Chaerunisaa AY; Muhaimin M; Joni IM
    Nanomaterials (Basel); 2022 Nov; 12(22):. PubMed ID: 36432358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.
    Abid R; Ghazanfar S; Farid A; Sulaman SM; Idrees M; Amen RA; Muzammal M; Shahzad MK; Mohamed MO; Khaled AA; Safir W; Ghori I; Elasbali AM; Alharbi B
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the phytochemicals of
    Gurung AB; Ali MA; Lee J; Aljowaie RM; Almutairi SM
    J King Saud Univ Sci; 2022 Aug; 34(6):102155. PubMed ID: 35702062
    [No Abstract]   [Full Text] [Related]  

  • 60. Tale of Viruses in Male Infertility.
    Das S; Mondal A; Samanta J; Chakraborty S; Sengupta A
    Adv Exp Med Biol; 2022; 1358():275-323. PubMed ID: 35641875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.